Univariate and Multivariate Cox Regression Analysis for Occurrence of MACE
| Univariate | Multivariate | |||||
| Characteristic | Hazard ratio | 95% confidence interval | P | Hazard ratio | 95% confidence interval | P |
| Age | 0.999 | 0.967–1.032 | 0.945 | |||
| NYHA class IV | 1.589 | 0.536–4.312 | 0.404 | |||
| BNP | 1.000 | 0.999–1.001 | 0.160 | 1.001 | 0.999–1.002 | 0.086 |
| Hypertension | 1.833 | 0.246–13.677 | 0.554 | |||
| Dyslipidemia | 1.259 | 0.512–3.097 | 0.615 | |||
| Diabetes mellitus | 0.947 | 0.404–2.220 | 0.901 | |||
| Previous myocardial infarction | 1.920 | 0.446–8.261 | 0.381 | |||
| SSS | 1.009 | 0.966–1.055 | 0.683 | |||
| SRS | 1.003 | 0.964–1.044 | 0.866 | |||
| Low MBR-IR | 3.640 | 1.456–9.103 | 0.006 | 3.913 | 1.552–9.868 | 0.004 |
| Rest LVEF | 0.992 | 0.964–1.020 | 0.576 | |||
| Treatment after MPI | ||||||
| PCI | 1.601 | 0.538–4.761 | 0.398 | |||
| CABG | 0.771 | 0.179–3.309 | 0.726 | |||
| Nicorandil | 1.091 | 0.471–2.529 | 0.839 | |||
| ARB | 1.639 | 0.598–4.495 | 0.337 | |||
| β-blocker | 1.013 | 0.298–3.451 | 0.983 | |||
| Statin | 1.359 | 0.528–3.501 | 0.525 | |||
NYHA = New York Heart Association; BNP = brain natriuretic peptide; SSS = summed stress score; SRS = summed rest score; MPI = myocardial perfusion imaging; PCI = percutaneous coronary intervention; CABG = coronary artery bypass grafting; ARB = angiotensin receptor blocker; ICD = implantable cardioverter-defibrillator.